Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -143.54% is 67% below its 5-year average of -85.79%, near the low end of its 5-year range (-143.54%–-43.73%).
As of the fiscal period ended Sunday, May 31, 2026. 29.97% below its 12-month average of -110.44%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-05-31): -143.54%.
RETURN ON EQUITY (ROE)
-143.54%
RETURN ON EQUITY (ROE) AVG TTM
-110.44%
RETURN ON EQUITY (ROE) AVG 3Y
-93.84%
RETURN ON EQUITY (ROE) AVG 5Y
-85.79%
RETURN ON EQUITY (ROE) AVG 10Y
-61.73%
RETURN ON EQUITY (ROE) AVG 15Y
-45.58%
RETURN ON EQUITY (ROE) AVG 20Y
-28.77%
CURRENT VS TTM AVG
-29.97%
CURRENT VS 3Y AVG
-52.95%
CURRENT VS 5Y AVG
-67.31%
CURRENT VS 10Y AVG
-132.52%
CURRENT VS 15Y AVG
-214.93%
CURRENT VS 20Y AVG
-398.84%
SECTOR MEDIAN · HEALTHCARE
-38.33%
median of 447 covered companies
CURRENT VS SECTOR MEDIAN
-274.47%
vs the sector median at left
Biomerica, Inc.
Market Cap
$6.46M
Return on Equity (ROE)
-143.54%
TTM Avg
-110.44%
3Y Avg
-93.84%
5Y Avg
-85.79%
Market Cap
$6.41M
Return on Equity (ROE)
N/A
TTM Avg
-266.00%
3Y Avg
851.50%
5Y Avg
629.05%
Market Cap
$6.72M
Return on Equity (ROE)
-227.37%
TTM Avg
-118.13%
3Y Avg
-87.25%
5Y Avg
-55.09%
Market Cap
$6.19M
Return on Equity (ROE)
-92.44%
TTM Avg
-28.72%
3Y Avg
10.69%
5Y Avg
23.75%
Market Cap
$6.85M
Return on Equity (ROE)
-108.00%
TTM Avg
-445.77%
3Y Avg
-254.63%
5Y Avg
-239.85%
Market Cap
$6.80M
Return on Equity (ROE)
-54.09%
TTM Avg
-388.62%
3Y Avg
-105.04%
5Y Avg
-44.72%
Market Cap
$6.25M
Return on Equity (ROE)
-304.78%
TTM Avg
-566.96%
3Y Avg
-321.57%
5Y Avg
-251.82%
Market Cap
$6.10M
Return on Equity (ROE)
-87.12%
TTM Avg
-90.45%
3Y Avg
-143.11%
5Y Avg
-272.17%
Market Cap
$6.29M
Return on Equity (ROE)
105.35%
TTM Avg
0.10%
3Y Avg
-37.77%
5Y Avg
-33.57%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.46M | -143.54% | -110.44% | -93.84% | -85.79% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.41M | N/A | -266.00% | 851.50% | 629.05% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -227.37% | -118.13% | -87.25% | -55.09% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.19M | -92.44% | -28.72% | 10.69% | 23.75% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.85M | -108.00% | -445.77% | -254.63% | -239.85% |
| Aclarion, Inc. (ACON)vs › | $6.80M | -54.09% | -388.62% | -105.04% | -44.72% |
| Femasys Inc. (FEMY)vs › | $6.25M | -304.78% | -566.96% | -321.57% | -251.82% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -87.12% | -90.45% | -143.11% | -272.17% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.29M | 105.35% | 0.10% | -37.77% | -33.57% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | -370.16% | -148.31% | -87.53% | -43.20% |
ROE
-143.5%
ROA
-55.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-05-31 | -143.54% |
| 2026-02-28 | -125.84% |
| 2025-11-30 | -90.76% |
| 2025-08-31 | -70.90% |
| 2025-05-31 | -121.14% |
| 2025-02-28 | -87.64% |
| 2024-11-30 | -109.60% |
| 2024-08-31 | -115.26% |
| 2024-05-31 | -90.70% |
| 2024-02-29 | -81.32% |
| 2023-11-30 | -64.81% |
| 2023-08-31 | -57.58% |
| 2023-05-31 | -60.90% |
| 2023-02-28 | -118.72% |
| 2022-11-30 | -76.78% |
| 2022-08-31 | -60.81% |
| 2022-05-31 | -54.43% |
| 2022-02-28 | -43.73% |
| 2021-11-30 | -70.64% |
| 2021-08-31 | -78.16% |
| 2021-05-31 | -78.36% |
| 2021-02-28 | -58.70% |
| 2020-11-30 | -44.47% |
| 2020-08-31 | -29.61% |
| 2020-05-31 | -16.46% |
| 2020-02-29 | -56.35% |
| 2019-11-30 | -72.74% |
| 2019-08-31 | -67.54% |
| 2019-05-31 | -60.11% |
| 2019-02-28 | -57.54% |
| 2018-11-30 | -43.50% |
| 2018-08-31 | -41.94% |
| 2018-05-31 | -33.89% |
| 2018-02-28 | -28.60% |
| 2017-11-30 | -27.96% |
| 2017-08-31 | -24.73% |
| 2017-05-31 | -20.23% |
| 2017-02-28 | -37.10% |
| 2016-11-30 | -32.26% |
| 2016-08-31 | -28.71% |
| 2016-05-31 | -28.73% |
| 2016-02-29 | -0.58% |
| 2015-11-30 | -0.24% |
| 2015-08-31 | -3.33% |
| 2015-05-31 | -5.92% |
| 2015-02-28 | -7.58% |
| 2014-11-30 | -4.80% |
| 2014-08-31 | -4.69% |
| 2014-05-31 | -3.65% |
| 2014-02-28 | -5.94% |
| 2013-11-30 | -7.42% |
| 2013-08-31 | 1.37% |
| 2013-05-31 | 9.20% |
| 2013-02-28 | 9.90% |
| 2012-11-30 | 13.86% |
| 2012-08-31 | 13.71% |
| 2012-05-31 | 11.02% |
| 2011-02-28 | -2.56% |
| 2010-11-30 | -1.13% |
| 2010-08-31 | -8.68% |
| 2010-05-31 | -8.16% |
| 2010-02-28 | -2.95% |
| 2009-11-30 | 0.46% |
| 2009-08-31 | 5.08% |
| 2009-05-31 | 8.15% |
| 2009-02-28 | 23.75% |
| 2008-11-30 | 21.63% |
| 2008-08-31 | 23.79% |
| 2008-05-31 | 44.03% |
| 2008-02-29 | 44.79% |
| 2007-11-30 | 47.39% |
| 2007-08-31 | 52.42% |
| 2007-05-31 | 33.81% |
| 2007-02-28 | 31.58% |
| 2006-11-30 | 27.16% |
| 2006-08-31 | 20.05% |
| 2006-05-31 | 21.65% |
| 2006-02-28 | 35.60% |
| 2005-11-30 | 32.78% |
| 2005-08-31 | 25.93% |
| 2005-05-31 | 15.41% |
| 2005-02-28 | -0.20% |
| 2004-11-30 | -1.35% |
| 2004-08-31 | -6.32% |
| 2004-05-31 | -24.10% |
| 2004-02-29 | -15.15% |
| 2003-11-30 | -26.38% |
| 2003-08-31 | -28.50% |
| 2003-05-31 | -19.04% |
